DRUG
Bright Minds·NASDAQ
--
--(--)
--
--(--)
7.90 / 10
Outperform
Sentiment is Outperform (7.9) and fund‑flow score 7.75 (good), with modest overall inflow (48%). Small‑cap investors are net positive, while larger blocks are net negative. Analyst consensus is 100% Strong Buy from two analysts, reinforcing bullish sentiment despite recent price decline.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-04
InstitutionHC Wainwright & Co.
Times predicted4
Historical Win Rate75.0%
Is money flowing into or out of DRUG?
- DRUG holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.90/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
